Results 261 to 270 of about 114,465,275 (302)

Active Peyronie's disease as an early antifibrotic treatment window: a translational review. [PDF]

Sex Med
Broul M, Liegertová M, Hujová A, Vostrý M.   +3 more
europepmc   +1 more source

Preimplantation Genetic Testing for Families at Risk of Haemophilia: Ten-Year Single-Centre Experience. [PDF]

Haemophilia
Mortarino M, Garagiola I, Nicotra V, Riccaboni A, Guarneri C, Somigliana E, Peyvandi F.   +6 more
europepmc   +1 more source

Nanomaterial-enabled delivery of plant-derived bioactive metabolites for diabetic retinopathy: from evidence appraisal to preclinical translation. [PDF]

Front Pharmacol
Zhao D, Wang C, Jiang Z, Xu Y, Xia Y, Zhang P, Ye H.   +6 more
europepmc   +1 more source

Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning. [PDF]

Mol Pharm
Käser S, Bassani D, Parrott NJ, Umehara K, Delporte ML, David-Pierson P.   +5 more
europepmc   +1 more source

ESTABLISHMENT AND CHARACTERIZATION OF A CONTINUOUS MURINE UTERINE CERVIX CANCER CELL-LINE METASTATIC TO LYMPH-NODES AND LUNGS

, 1987
GAO, J, LIU, Y, MAREEL, M, WANG, JX, QIAN, SS, CAI, YY, DONG, HY, DEBRUYNE, G, LI, BG   +8 more
core  

Testing CC freeze

Testing, A
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An in vitro model for preclinical testing of thrombogenicity of resorbable metallic stents

Journal of Biomedical Materials Research Part A, 2014
AbstractVascular stents that can biodegrade and disappear in time have been reported as a promising solution to the problems of late‐stent thrombosis and in‐stent restenosis. Iron alloys in particular have many advantages in terms of cytocompatibility and mechanical properties.
Emily K, Walker, Eric A, Nauman, Jean Paul, Allain, Lia A, Stanciu   +3 more
openaire   +2 more sources

49. Combined treatments with Hadrontherapy – in vitro tests and preclinical approach

Physica Medica, 2018
Purpose Glioblastoma multiforme (GBM) is the most aggressive types of central nervous system tumors. The aim of the project is to validate an innovative molecule developed by Lead Discovery Siena [LDS] showing inhibitory activity against Src kinases to be associated with proton therapy treatments.
G. Russo, P. Pisciotta, V. Marchese, F.P. Cammarata, L. Minafra, G.I. Forte, V. Bravatà, G.A.P. Cirrone, A.L. Fallacara, L. Maccari, F. Torrisi, G. Calabrese, R. Parenti, M. Botta, G. Cuttone   +14 more
openaire   +1 more source

In vitro and in vivo testing of a novel local nicardipine delivery system to the brain: a preclinical study

Journal of Neurosurgery, 2020
OBJECTIVEThe management of patients with aneurysmal subarachnoid hemorrhage (aSAH) remains a highly demanding challenge in critical care medicine. Despite all efforts, the calcium channel antagonist nimodipine remains the only drug approved for improving outcomes after aSAH.
Simon H, Bayerl, Adnan, Ghori, Melina, Nieminen-Kelhä, Tiziana, Adage, Jörg, Breitenbach, Peter, Vajkoczy, Vincent, Prinz   +6 more
openaire   +2 more sources